Statement: Participants in the primary trial receive different interventions depending on their cancer hormone status, so Triple-Negative patients are seperated from HER2+ patients for example, whereas all patients in the secondary trial took the same intervention.
Primary_evidence: INTERVENTION 1:    Pre-diagnosed Breast Cancer - Biopsy Confirmed   Low-power microwave breast imaging system.   Core needle biopsy performed 14 days before the microwave breast investigation   Low-power microwave breast imaging system: Investigate the capacity of microwave imaging to detect and characterise diagnosed palpable breast lump INTERVENTION 2:    Pre-diagnosed Breast Cyst   Low-power microwave breast imaging system.   No prior biopsy   Low-power microwave breast imaging system: Investigate the capacity of microwave imaging to detect and characterise diagnosed palpable breast lump
Secondary_evidence: INTERVENTION 1:    Cohort A: Advanced Triple-Negative Breast Cancer (TNBC)   6 mg/kg IMGN853 IV Q3W